Page 13 - Josh Nathan Kazis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biogen Reports Earnings Wednesday Here s What to Expect

When Biogen reports earnings Wednesday, investors won’t be paying much attention to the numbers. Biogen is in a period of cost-cutting, and trying to build.

Vanessa leroy bloombergChris viehbacherMichael yeeMarc goodmanColin bristowJosh nathan kazisDrug administrationSage therapeuticsArticle normalOil and gas upstream operationsBiotechnology servicesHealthcare life sciencesOil and natural gas explorationFossil fuelsOil and gasFinancial performance

Vertex Pain Pill Could Replace Opioids It s an Opportunity for Investors

The new Vertex pain pill is in trials now. Investors might want to make their bets soon.

United statesSan diegoLeerink risingerSalveen richterDavid risingerJosh nathan kazisChoi chanStephen waxmanMarks wallaceRegeneron pharmaceuticalsUniversity of californiaDrug administrationGoldman sachsVertex pharmaceuticalsLeerink partnersEli lilly

Stock Selloff On Ozempic and Wegovy Fears is an Overreaction, Says Novo CEO

Novo Nordisk’s CEO thinks the concern over how Ozempic and Wegovy will impact other industries is overblown.

United statesJosh nathan kazisLars fruergaardNovo nordiskWall streetAbbott laboratoriesArticle normalMedical equipment suppliesFood beveragesRetail wholesaleHealthcare life sciencesConsumer goodsSpecialized drugs medicationsFood productsHormone productsDiabetes drugs

Novo Nordisk Reports Earnings Thursday Wegovy and Ozempic Will Be in Focus

Novo Nordisk Reports Earnings Thursday Wegovy and Ozempic Will Be in Focus
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

United statesCarsten snejbjerg bloombergJosh nathan kazisNovo nordiskEli lillyPharmaceutical index

GSK Reports Earnings Wednesday Here s What to Expect

The U.K. drugmaker GSK reports earnings Wednesday morning, in the midst of what’s been a perilous season for pharmaceutical results.

United statesKsenia kuleshova bloombergJosh nathan kazisBristol myers squibbEli lillyNovo nordiskArticle normalAgricultural machineryRetail wholesaleHealthcare life sciencesIndustrial goodsFinancial performanceCorporate industrial newsContent typesFactiva filtersC amp ampe industry news filter